Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Meeting ReportPoster - PhysicianPharm

Is FDG maximum standardized uptake value (SUV max) of primary breast cancer can predict axillary lymph node metastasis?

Asmaa Abd elaal, Ahmad Zaher, Marwa Khalifa, Mohamed Meckawy and Lamiaa Eloteify
Journal of Nuclear Medicine May 2021, 62 (supplement 1) 1097;
Asmaa Abd elaal
1Oncology and Nuclear Medicine Assiut university hospital Assiut Egypt
3Oncology and Nuclear Medicine Assiut university hospital Assiut Egypt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ahmad Zaher
2Oncology and Nuclear Medicine National cancer institute. Cairo university Cairo Egypt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marwa Khalifa
1Oncology and Nuclear Medicine Assiut university hospital Assiut Egypt
3Oncology and Nuclear Medicine Assiut university hospital Assiut Egypt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohamed Meckawy
1Oncology and Nuclear Medicine Assiut university hospital Assiut Egypt
3Oncology and Nuclear Medicine Assiut university hospital Assiut Egypt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lamiaa Eloteify
1Oncology and Nuclear Medicine Assiut university hospital Assiut Egypt
3Oncology and Nuclear Medicine Assiut university hospital Assiut Egypt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1097

Background: Functional imaging with 18F-fluoro-2-deoxy-D-glucose (18F-FDG) positron emission tomography/computed tomography(PET/CT) is increasingly used for diagnosis and staging and restaging of breast cancer (BC) patients.

Purpose: To evaluate the validity of 18F-FDG PET/CT metabolic activity parameter maximum standardized uptake value of the primary tumor (SUVmax-T) to predict locoregional axillary lymph node metastasis (ALNM) in initial staging of BC patients. Materials and Methods: We prospectively studied 40 female patients with different stages pathologically proven breast cancer. All patients were submitted to 18F-FDG PET/CT imaging for their initial tumor staging. The SUVmax-T and SUVmax ALN on 18F-FDGPET/CT were assessed. The patients were categorized into two groups; group I, with positive ALN uptake, and groupII with negative ALN uptake, according to the presence of locoregional 18F-FDG ALN uptake on visual &quantitative analysis of 18F-FDG PET/CT. The correlations and differences between two groups were statistically evaluated. The optimal cut-off value of SUVmax-T was determined.

Results: Forty female patients with newly diagnosed BC were included in our study, age range from 31-78 (mean 50.5 +/- SD11.7). All the 1ry tumors were detected with mean SUVmax 10.8(+/-SD 7.9). In the Twenty-Three patients who underwent nodal staging (axillary dissection in 7/23 patients and SLNBs in 16/23 patients.), 13/23 and 10/23 patients were positive and negative for metastases respectively.PET/CT was positive in 27 patients with ALNs; out of them 13 proved true positive, 4 were false positive by histopathology and in the remaining 10 cases no pathology report was available. PET/CT negative axillary cases were 13 out of them 6 were true negative by histopathology and in the remaining 7 cases no pathology report were available. The mean tumor size in group I was significantly greater than that in group II (3.1+/- SD 1 , P value 0.011). The mean SUVmax-T value in group A was significantly higher than that in group B ((Mean 12.7+/- SD 8.6 ,Pvalue 0.016). Tumor stage &nuclear grade in group A was higher than that in group B (P value 0.372, 0.252 respectively). SUVmax -T were significantly moderately positively correlated with the size of the 1ry tumor (rho= 0.328, P value=0.019 . SUVmax -T was predictive of axillary nodal involvement AUC= 0.735(95% CI: 0.577-0.893). The optimal cut-off of SUVmax-T for detecting ALNM was>1.9 gives sensitivity 100% and specificity 92%. with overall sensitivity and specificity of PET/CT for axillary staging was 100 % and 60 %, respectively (P value= 0.006).

Conclusions: BC patients with higher FDG SUVmax of primary tumor are at greater risk of concurrent ALNM. Keywords: Breast cancer. FDG PET/CT . SUVmax. Initial staging. Axillary lymph nodal metastasis, prognosis.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 62, Issue supplement 1
May 1, 2021
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Is FDG maximum standardized uptake value (SUV max) of primary breast cancer can predict axillary lymph node metastasis?
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Is FDG maximum standardized uptake value (SUV max) of primary breast cancer can predict axillary lymph node metastasis?
Asmaa Abd elaal, Ahmad Zaher, Marwa Khalifa, Mohamed Meckawy, Lamiaa Eloteify
Journal of Nuclear Medicine May 2021, 62 (supplement 1) 1097;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Is FDG maximum standardized uptake value (SUV max) of primary breast cancer can predict axillary lymph node metastasis?
Asmaa Abd elaal, Ahmad Zaher, Marwa Khalifa, Mohamed Meckawy, Lamiaa Eloteify
Journal of Nuclear Medicine May 2021, 62 (supplement 1) 1097;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Poster - PhysicianPharm

  • Preliminary result of Texture Analysis on prediction of overall outcome of neuroendocrine tumors based on pre-therapy heterogeneity of somatostatin receptors on 68Ga Dotatate PET/CT scans.
  • The Incremental Value of 18F FDG Labelled Leukocytes PET/CT Over 18F FDG PET/CT Scan in the Detection of Occult Infection
  • Spontaneous Coronary Artery Dissection: A Novel Application of FDG/PET
Show more Poster - PhysicianPharm

Breast Cancer

  • Application of machine learning analyses using clinical and radiomic features of 18F-FDG PET/CT to predict postoperative recurrence of breast cancer
  • Diagnostic accuracy of 18F-FDG PET/CT in determining recurrence in patients with triple-negative breast cancer – A retrospective study.
  • BREAST CANCER. INCIDENCE OF NEW LESIONS DETECTED BY HIGH RESOLUTION BREAST PET WITH 18F-FDG NOT SEEN ON THE MAMMOGRAPHY
Show more Breast Cancer

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire